Skip to main content

Table 3 Select CYP3A4 inhibitors and substrates among the components of Genvoya® and simvastatine

From: Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya® (EVG/COBI/FTC/TAF) and simvastatin; a case report

Inhibitors CYP3A4

Substrates CYP3A4

Cobicistat

Elvitegravir

Simvastatine

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us